Jenne Kyle's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Mar 11, 2026
- Accession no.
- 0000874015-26-000142
- Filed
- Mar 11, 2026
- Trade date
- Mar 10, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.83M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jenne KyleCIK 0001791857 | Officer (EVP, Chf GL Pdt Str Ofcr) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Common Stock | MOption exerciseAcquired | +32,602 | $46.10 | +$1,502,952.2 | 48,991 | Direct | |
| Mar 10, 2026 | Common Stock | SSaleDisposed | −21,191 | $75.50 | −$1,599,920.5 | 27,800 | Direct | |
| Mar 10, 2026 | Common Stock | SSaleDisposed | −16,086 | $76.30 | −$1,227,361.8 | 11,714 | Direct | |
| Mar 10, 2026 | Common Stock | MOption exerciseAcquired | +4,675 | $34.69 | +$162,175.75 | 16,389 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Common Stock | MOption exerciseDisposed | −4,675 | $0.00 | $0 | 14,025 | Direct | |
| Mar 10, 2026 | Common Stock | MOption exerciseDisposed | −32,602 | $0.00 | $0 | 32,601 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.